Literature DB >> 6315928

Fine-structural alterations in Leishmania tropica within human macrophages exposed to antileishmanial drugs in vitro.

S G Langreth, J D Berman, G P Riordan, L S Lee.   

Abstract

The mechanism of action of antileishmanial compounds is poorly understood. Ultrastructural changes in Leishmania tropica within human macrophages exposed in vitro to Pentostam, pentamidine, amphotericin B, WR 6026, ketoconazole, and Formycin B were examined in these experiments. In Pentostam-treated cultures, some organisms exhibited diminished definition of mitochondrial and other membranes, while other organisms had completely disintegrated. Pentostam-exposed macrophages demonstrated loss of membrane definition in the absence of further alterations; it is therefore hypothesized that impaired macrophage membrane function may contribute towards the effect of this drug against macrophage-contained organisms. Leishmania parasites in pentamidine-treated cultures initially demonstrated swollen kinetoplasts and fragmentation of the kinetoplast DNA core. The initial observed effect of the other four drugs on the parasites was cytoplasmic condensation. These ultrastructural studies suggest that all five non-antimonial drugs may have different mechanisms of action than antimony (Pentostam) against Leishmania.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315928     DOI: 10.1111/j.1550-7408.1983.tb01421.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  7 in total

1.  Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  K Lazardi; J A Urbina; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases.

Authors:  Hector Nakayama; Philippe M Loiseau; Christian Bories; Susana Torres de Ortiz; Alicia Schinini; Elsa Serna; Antonieta Rojas de Arias; Mohamed A Fakhfakh; Xavier Franck; Bruno Figadère; Reynald Hocquemiller; Alain Fournet
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Antileishmanial activity of an indole alkaloid from Peschiera australis.

Authors:  J C Delorenzi; M Attias; C R Gattass; M Andrade; C Rezende; A da Cunha Pinto ; A T Henriques; D C Bou-Habib; E M Saraiva
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi.

Authors:  K Lazardi; J A Urbina; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

5.  Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate.

Authors:  J D Berman; D Waddell; B D Hanson
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

Review 6.  Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance.

Authors:  P M Loiseau; S Cojean; J Schrével
Journal:  Parasite       Date:  2011-05       Impact factor: 3.000

7.  Structures, targets and recent approaches in anti-leishmanial drug discovery and development.

Authors:  Karin Seifert
Journal:  Open Med Chem J       Date:  2011-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.